IGG4 RELATED DISEASE
Clinical trials for IGG4 RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IGG4 RELATED DISEASE trials appear
Sign up with your email to follow new studies for IGG4 RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop dangerous flare-ups in rare autoimmune disease
Disease control OngoingThis study tests a drug called inebilizumab to see if it can prevent flare-ups in people with IgG4-related disease, a rare condition where the immune system attacks the body's own tissues. The trial involves 135 adults who have recently had a flare and need steroid treatment. The…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 16, 2026 22:34 UTC
-
New drug aims to stop rare autoimmune disease flares
Disease control OngoingThis study tests whether the drug obexelimab can prevent flare-ups in people with IgG4-related disease, a rare autoimmune condition that causes swelling and damage to organs. About 194 adults with active disease will receive either obexelimab or a placebo, and researchers will tr…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE3 • Sponsor: Zenas BioPharma (USA), LLC • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC